Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Amber M. Amparo"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Despite significant advancements in the treatment of other cancers, pancreatic ductal adenocarcinoma (PDAC) remains one of the world’s deadliest cancers. More than 90% of PDAC patients harbor a Kirsten rat sarcoma (KRAS) gene mutation. Although the
Externí odkaz:
https://doaj.org/article/0c5e0322ec554d5fb850e9054dca99f9
Autor:
Craig M. Goodwin, Andrew M. Waters, Jennifer E. Klomp, Sehrish Javaid, Kirsten L. Bryant, Clint A. Stalnecker, Kristina Drizyte-Miller, Bjoern Papke, Runying Yang, Amber M. Amparo, Irem Ozkan-Dagliyan, Elisa Baldelli, Valerie Calvert, Mariaelena Pierobon, Jessica A. Sorrentino, Andrew P. Beelen, Natalie Bublitz, Mareen Lüthen, Kris C. Wood, Emanuel F. Petricoin, Christine Sers, Autumn J. McRee, Adrienne D. Cox, Channing J. Der
Publikováno v:
Cancer Res
Mutational loss of CDKN2A (encoding p16INK4A) tumor-suppressor function is a key genetic step that complements activation of KRAS in promoting the development and malignant growth of pancreatic ductal adenocarcinoma (PDAC). However, pharmacologic res
Autor:
Channing J. Der, Adrienne D. Cox, Autumn J. McRee, Christine Sers, Emanuel F. Petricoin, Kris C. Wood, Mareen Lüthen, Natalie Bublitz, Andrew P. Beelen, Jessica A. Sorrentino, Mariaelena Pierobon, Valerie Calvert, Elisa Baldelli, Irem Ozkan-Dagliyan, Amber M. Amparo, Runying Yang, Bjoern Papke, Kristina Drizyte-Miller, Clint A. Stalnecker, Kirsten L. Bryant, Sehrish Javaid, Jennifer E. Klomp, Andrew M. Waters, Craig M. Goodwin
Figure S7 page2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0acddd6baeccef281cd7c89ad06c366e
https://doi.org/10.1158/0008-5472.22432947
https://doi.org/10.1158/0008-5472.22432947
Autor:
Channing J. Der, Adrienne D. Cox, Autumn J. McRee, Christine Sers, Emanuel F. Petricoin, Kris C. Wood, Mareen Lüthen, Natalie Bublitz, Andrew P. Beelen, Jessica A. Sorrentino, Mariaelena Pierobon, Valerie Calvert, Elisa Baldelli, Irem Ozkan-Dagliyan, Amber M. Amparo, Runying Yang, Bjoern Papke, Kristina Drizyte-Miller, Clint A. Stalnecker, Kirsten L. Bryant, Sehrish Javaid, Jennifer E. Klomp, Andrew M. Waters, Craig M. Goodwin
Supplementary Data and Materials
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::306f3e6cb9bdc08cf8212e98818fdca1
https://doi.org/10.1158/0008-5472.22432941
https://doi.org/10.1158/0008-5472.22432941
Autor:
Channing J. Der, Adrienne D. Cox, Autumn J. McRee, Christine Sers, Emanuel F. Petricoin, Kris C. Wood, Mareen Lüthen, Natalie Bublitz, Andrew P. Beelen, Jessica A. Sorrentino, Mariaelena Pierobon, Valerie Calvert, Elisa Baldelli, Irem Ozkan-Dagliyan, Amber M. Amparo, Runying Yang, Bjoern Papke, Kristina Drizyte-Miller, Clint A. Stalnecker, Kirsten L. Bryant, Sehrish Javaid, Jennifer E. Klomp, Andrew M. Waters, Craig M. Goodwin
Mutational loss of CDKN2A (encoding p16INK4A) tumor-suppressor function is a key genetic step that complements activation of KRAS in promoting the development and malignant growth of pancreatic ductal adenocarcinoma (PDAC). However, pharmacologic res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9aac2b4a73c2414e8aceef7834205187
https://doi.org/10.1158/0008-5472.c.6514275.v1
https://doi.org/10.1158/0008-5472.c.6514275.v1
Autor:
Channing J. Der, Adrienne D. Cox, Autumn J. McRee, Christine Sers, Emanuel F. Petricoin, Kris C. Wood, Mareen Lüthen, Natalie Bublitz, Andrew P. Beelen, Jessica A. Sorrentino, Mariaelena Pierobon, Valerie Calvert, Elisa Baldelli, Irem Ozkan-Dagliyan, Amber M. Amparo, Runying Yang, Bjoern Papke, Kristina Drizyte-Miller, Clint A. Stalnecker, Kirsten L. Bryant, Sehrish Javaid, Jennifer E. Klomp, Andrew M. Waters, Craig M. Goodwin
Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9063a982801a1d99eae9d4209128101a
https://doi.org/10.1158/0008-5472.22432938
https://doi.org/10.1158/0008-5472.22432938